- Home
- MVBF vs AVIR Comparison
MVBF vs AVIR Comparison
Compare MVBF & AVIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MVBF
- AVIR
- Stock Information
- Founded
- MVBF 1997
- AVIR 2012
- Country
- MVBF United States
- AVIR United States
- Employees
- MVBF N/A
- AVIR N/A
- Industry
- MVBF Major Banks
- AVIR Medicinal Chemicals and Botanical Products
- Sector
- MVBF Finance
- AVIR Health Care
- Exchange
- MVBF Nasdaq
- AVIR Nasdaq
- Market Cap
- MVBF 281.6M
- AVIR 247.5M
- IPO Year
- MVBF N/A
- AVIR 2020
- Fundamental
- Price
- MVBF $20.26
- AVIR $3.25
- Analyst Decision
- MVBF Buy
- AVIR Hold
- Analyst Count
- MVBF 2
- AVIR 1
- Target Price
- MVBF $27.50
- AVIR $6.88
- AVG Volume (30 Days)
- MVBF 36.7K
- AVIR 503.8K
- Earning Date
- MVBF 02-12-2025
- AVIR 11-07-2024
- Dividend Yield
- MVBF 3.36%
- AVIR N/A
- EPS Growth
- MVBF N/A
- AVIR N/A
- EPS
- MVBF 1.41
- AVIR N/A
- Revenue
- MVBF $140,251,000.00
- AVIR N/A
- Revenue This Year
- MVBF N/A
- AVIR N/A
- Revenue Next Year
- MVBF $7.90
- AVIR N/A
- P/E Ratio
- MVBF $14.39
- AVIR N/A
- Revenue Growth
- MVBF N/A
- AVIR N/A
- 52 Week Low
- MVBF $17.51
- AVIR $2.75
- 52 Week High
- MVBF $25.24
- AVIR $4.60
- Technical
- Relative Strength Index (RSI)
- MVBF 42.84
- AVIR 53.42
- Support Level
- MVBF $19.50
- AVIR $3.10
- Resistance Level
- MVBF $21.49
- AVIR $3.32
- Average True Range (ATR)
- MVBF 0.75
- AVIR 0.15
- MACD
- MVBF -0.20
- AVIR 0.03
- Stochastic Oscillator
- MVBF 26.12
- AVIR 88.50
About MVBF MVB Financial Corp.
MVB Financial Corp is a bank holding company. The company provides community banking, mortgage banking, insurance and wealth management services to individuals and corporate clients in the Mid-Atlantic region. The Bank offers its customers various products, such as checking accounts, negotiable order of withdrawal (NOW) accounts, money market and savings accounts, time certificates of deposit, commercial, installment, commercial real estate and residential real estate mortgage loans, debit cards, and safe deposit rental facilities. MVB has three reportable segments: CoRe banking; mortgage banking and the financial holding company. It generates majority of its revenues from its CoRe banking segment.
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).